课题基金 / 基金详情

TREATMENT AND OUTCOME OF EARLY ONSET BIPOLAR DISORDER

TREATMENT AND OUTCOME OF EARLY ONSET BIPOLAR DISORDER
早发性双相情感障碍的治疗和结果
批准号:
6530906
负责人:
VIVIAN KAFANTARIS
金额:
$64.96万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-01 至 2003-02-28

项目摘要

项目成果

VIVIAN KAFANTARIS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自申请人摘要):双相情感障碍的发病
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Onset of bipolar disorder during adolescence increases the risk of school failure, out-of-home placement, drug abuse and addiction, and suicide. In adolescents, bipolar disorder is often accompanied by delusions, hallucinations, or severe assaultive or destructive behaviors that require acute treatment with adjunctive antipsychotic medication in addition to a mood stabilizer. There are no data on when to withdraw antipsychotic medication or whether to withdraw it at all. Although it is important to identify patients who could be maintained on lithium alone to decrease the risk of developing long-term adverse effects such as tardive dyskinesia (TD), it is also important to prevent disruptive recurrences of episodes of illness. There is a high rate of failure on lithium maintenance treatment in general. For adolescents who have had psychotic features or assaultive, destructive behavior as part of their mania, continued adjunctive antipsychotic medication may offer additional prophylactic efficacy. In addition, a lower risk of TD with the novel antipsychotics may alter the risk: benefit ratio in favor of longer-term antipsychotic treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3 ACISR
CLINICAL TRIAL: PEDIATRIC STUDY OF LITHIUM FOR THE TREATMENT OF PEDIATRIC MANIA
GENETICS OF EARLY-ONSET BIPOLAR DISORDER
CLINICAL TRIAL: PEDIATRIC PHARMACOKINETIC AND TOLERABILITY STUDY OF LITHIUM FOR
海外基金